Current Nanomedicine
Title:Meet Our Associate Editorial Board Member
Volume: 10 Issue: 1
Author(s): Ayça Bal Ozturk
Affiliation:
Export Options
About this article
Cite this article as:
Ozturk Bal Ayça, Meet Our Associate Editorial Board Member, Current Nanomedicine 2020; 10 (1) . https://dx.doi.org/10.2174/246818731001200306104139
DOI https://dx.doi.org/10.2174/246818731001200306104139 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
16
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency
Current Molecular Pharmacology Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Gene Directed Enzyme Prodrug Therapy for Ovarian Cancer: Could GDEPT Become a Promising Treatment Against Ovarian Cancer?
Anti-Cancer Agents in Medicinal Chemistry Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Current Cancer Drug Targets In Silico Studies Most Employed in the Discovery of New Antimicrobial Agents
Current Medicinal Chemistry Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Cardiovascular & Hematological Disorders-Drug Targets Metastasis-Inducing S100A4 Protein: Implication in Non-Malignant Human Pathologies
Current Molecular Medicine Marine Peptides and Related Compounds in Clinical Trial+
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Intervention in Markovian Regulatory Networks
Current Genomics Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design Coenzyme Q10 Attenuates Cisplatin-induced Nephrotoxicity Through Counteracting Oxidative Stress and Inflammation
Clinical Cancer Drugs Antiviral Treatment of HCV Carriers with Persistently Normal ALT Levels
Mini-Reviews in Medicinal Chemistry Clinical and Genetic Features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) Syndrome
Current Molecular Medicine Discovery of P3971 an Orally Efficacious Novel Anticancer Agent Targeting HIF-1α and STAT3 Pathways
Anti-Cancer Agents in Medicinal Chemistry Circulating Nucleic Acids as a Potential Source for Cancer Biomarkers
Current Molecular Medicine Interactions Between Probiotic Dairy Propionibacteria and the Intestinal Epithelium
Current Immunology Reviews (Discontinued) The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Integrative Approaches for microRNA Target Prediction: Combining Sequence Information and the Paired mRNA and miRNA Expression Profiles
Current Bioinformatics